
-
Jubilant Peruvians celebrate new pope at mass in adoptive city
-
Scottish refinery closure spells trouble for green transition
-
Convicted ex-Panama president Martinelli granted asylum in Colombia
-
IPL chiefs in talks about restart following ceasefire: reports
-
Navarrete beats Suarez on technical decision to keep title
-
Scans clear Wallabies fly-half Lolesio of serious back injury
-
Leo XIV to address faithful with St Peter's prayer
-
T-Wolves grab 2-1 NBA playoff series lead as Celtics get key win
-
Gaza war casts shadow over Cannes film festival
-
'Treasure hunt': tourists boost sales at Japan's Don Quijote stores
-
Cannes Festival: the films in competition
-
Cannes film festival: what to look out for
-
Jordan hospital treats war casualties from across Middle East
-
As Trump family's Gulf empire grows, rulers seek influence, arms, tech
-
S. Korea conservatives choose presidential candidate after last-minute chaos
-
Trump hails 'total reset' in US-China trade relations as talks continue
-
Film claims to name killer of slain journalist Shireen Abu Akleh
-
Under Trump pressure, Columbia University ends semester in turmoil
-
Putin proposes direct Ukraine talks but quiet on 30-day ceasefire
-
Trump hails US-China trade 'reset' after first day of talks
-
Jeeno leads Boutier by one at LPGA Americas Open
-
Lowry, Straka share lead at windy Truist
-
Messi suffers worst defeat in MLS as Miami fall again
-
Celtics overwhelm Knicks to pull within 2-1 in NBA playoff series
-
Toulouse crush Toulon to reach Top 14 semis as Castres pay tribute to Raisuqe
-
Marseille, Monaco clinch Champions League qualification from Ligue 1
-
'One of those days': Atletico record-breaker Sorloth hits four
-
Toulouse's Ntamack suffers concussion in Top 14, Willemse nears exit
-
Record-breaker Sorloth hits four as Atletico smash Real Sociedad
-
'Weight off my shoulders': Bayern's Kane toasts breakthrough title
-
Sinner grateful for 'amazing' support on Italian Open return from doping ban
-
Hamburg return to Bundesliga after seven-year absence
-
Toulouse's Ntamack suffers concussion in Top 14 clash
-
India, Pakistan reach ceasefire -- but trade claims of violations
-
'Long time coming': Bayern's Kane toasts breakthrough title
-
US, China conclude first day of trade talks in Geneva
-
Kane tastes first title as champions Bayern bid farewell to Mueller
-
Benfica deny Sporting to take Portuguese title race to wire
-
Sinner makes triumphant return from doping ban at Italian Open
-
Sinner wins at Italian Open in first match since doping ban
-
Leo XIV, new pope and 'humble servant of God', visits Francis's tomb
-
India claims Pakistan violated truce, says it is retaliating
-
Champions League race hots up as Man City held, Villa win
-
Kane tastes first title as champions Bayern see off Mueller
-
US envoy calls enrichment 'red line' ahead of new Iran talks
-
Hastoy lifts La Rochelle as Castres pay tribute to Raisuqe
-
Southampton avoid Premier League 'worst-ever' tag with Man City draw
-
Injury forces Saints quarterback Carr to retire
-
S.Korea conservative party reinstates candidate after day of turmoil
-
Verdict due Tuesday in Depardieu sexual assault trial

US surgeons transplant pig kidney to live patient in world first
US surgeons have successfully transplanted a genetically modified pig kidney into a living patient for the first time, the hospital said Thursday, a procedure that could help address the chronic shortage of donor organs.
The four-hour operation was carried out on Saturday on a 62-year-old man suffering from end-stage kidney disease, Massachusetts General Hospital said.
"The procedure marks a major milestone in the quest to provide more readily available organs to patients," the hospital known as Mass General, or MGH, said in a statement.
Organ shortages are a chronic problem around the world and the Boston hospital said there are more than 1,400 patients on the waiting list for a kidney transplant at MGH alone.
"Our hope is that this transplant approach will offer a lifeline to millions of patients worldwide who are suffering from kidney failure," said Dr Tatsuo Kawai, a member of the team which carried out the ground-breaking operation.
The hospital said the pig kidney used for the transplant was provided by a Massachusetts biotech company called eGenesis and had been genetically-edited to remove harmful pig genes and add certain human genes.
"This represents a new frontier in medicine and demonstrates the potential of genome engineering to change the lives of millions of patients globally suffering from kidney failure," said Mike Curtis, the chief executive officer of eGenesis.
The hospital said the patient, Richard Slayman of Weymouth, Massachusetts, "is recovering well at MGH and is expected to be discharged soon."
He will be on a regimen of immunosuppressive drugs to ward off rejection of the pig kidney.
Slayman, who suffers from Type 2 diabetes and hypertension, had received a transplant of a human kidney in 2018, but it began to fail five years later and he has been on dialysis.
Slayman said he agreed to the pig kidney transplant as "not only as a way to help me, but a way to provide hope for the thousands of people who need a transplant to survive."
- 'Health equity' -
Slayman is Black and the hospital said the procedure could be of particular benefit to ethnic minorities who suffer from high rates of kidney disease.
"This health disparity has been the target of many national policy initiatives for over 30 years, with only limited success," said Slayman's nephrologist Winfred Williams.
"An abundant supply of organs resulting from this technological advance may go far to finally achieve health equity and offer the best solution to kidney failure -– a well-functioning kidney –- to all patients in need," Williams said.
The transplantation of organs from one species to another is a growing field known as xenotransplantation.
Pig kidneys had been transplanted previously into brain dead patients, but Slayman is the first living person to receive one.
Genetically modified pig hearts were transplanted recently into two patients at the University of Maryland, but both survived less than two months.
Mass General said the pigs used as organ donors were "grown in isolation under special conditions to prevent the pig from being exposed to infections that might harm the human recipient."
"These special pigs have organs of similar size and function to human organs," it said. "The genetic modifications of these pigs have also made them more compatible with humans."
Mass General said the transplant was carried out under a policy known as "compassionate use" that allows patients with "serious or life-threatening conditions" to access experimental therapies not yet been approved by the Food and Drug Administration.
S.F.Warren--AMWN